Free EMR Newsletter Want to receive the latest news on EMR, Meaningful Use, ARRA and Healthcare IT sent straight to your email? Join thousands of healthcare pros who subscribe to EMR and HIPAA for FREE!!

London Doctors Stage Protest Over Rollout Of App

Posted on April 18, 2018 I Written By

Anne Zieger is a healthcare journalist who has written about the industry for 30 years. Her work has appeared in all of the leading healthcare industry publications, and she's served as editor in chief of several healthcare B2B sites.

We all know that doctors don’t take kindly to being forced to use health IT tools. Apparently, that’s particularly the case in London, where a group of general practitioners recently held a protest to highlight their problems with a telemedicine app rolled out by the National Health Service.

The doctors behind the protest are unhappy with the way the NHS structured its rollout of the smartphone app GP at Hand, which they say has created extra work and confusion among the patients.

The service, which is run by UK-based technology company Babylon Health, launched in November of last year. Using the app, patients can either have a telemedicine visit or schedule an in-person appointment with a GP’s office. Telemedicine services are available 24/7, and patients can be seen in minutes in some cases.

GP at Hand seems to be popular with British consumers. Since its launch, over 26,000 patients have registered for the service, according to the NHS.

However, to participate in the service, patients are automatically de-registered from their existing GP office when they register for GP at Hand. Many patients don’t seem to have known this. According to the doctors at the protest, they’ve been getting calls from angry former patients demanding that they be re-registered with their existing doctor’s office.

The doctors also suggest that the service gets to cherry-pick healthier, more profitable patients, which weighs down their practice. “They don’t want patients with complex mental health problems, drug problems, dementia, a learning disability or other challenging conditions,” said protest organizer Dr. Jackie Applebee. “We think that’s because these patients are expensive.” (Presumably, Babylon is paid out of a separate NHS fund than the GPs.)

Is there lessons here for US-based healthcare providers? Perhaps so.

Of course, the National Health Service model is substantially different from the way care is delivered in this country, so the administrative challenges involved in rolling out a similar service could be much different. But this news does offer some lessons to consider nonetheless.

For one thing, it reminds us that even in a system much different than ours, financing and organizing telemedicine services can be fraught with conflict. Reimbursement would be an even bigger issue than it seems to have been in the UK.

Also, it’s also of note that the NHS and Babylon Health faced a storm of patient complaints about the way the service was set up. It’s entirely possible that any US-based efforts would generate their own string of unintended consequences, the magnitude which would be multiplied by the fact that there’s no national entity coordinating such a rollout.

Of course, individual health systems are figuring out how to offer telemedicine and blend it with access to in-person care. But it’s telling that insurers with a national presence such as CIGNA or Humana aren’t plunging into telemedicine with both feet. At least none of them have seen substantial success in their efforts. Bottom line, offering telehealth is much harder than it looks.

Nokia May Exit Digital Health Business

Posted on March 2, 2018 I Written By

Anne Zieger is a healthcare journalist who has written about the industry for 30 years. Her work has appeared in all of the leading healthcare industry publications, and she's served as editor in chief of several healthcare B2B sites.

The digital health market has become phenomenally competitive over the last few years, with giants like Google and Apple duking it out with smaller, fast-moving startups over the choicest opportunities in the sector.

Even with a behemoth like Google, you expect to see some stumbles, and the Internet giant has taken a few. But seldom have we seen a billion-dollar company walk away from the digital health market, which arguably stands to grow far more. Still, according to a recent news report, that’s just what Nokia may be doing.

A story published in The Verge reports that the Finnish telecom giant has launched a strategic review of its health division. While Nokia apparently isn’t spilling the beans on its plans, the news site got a look at an internal company memo which suggests that its digital health business is indeed in trouble.

In the memo, The Verge says, Nokia chief strategy officer Kathrin Buvac wrote that “our digital health business has struggled to scale and meet its growth expectations… [And] currently, we don’t see a path for [the digital health business] to become a meaningful part of a company as large as Nokia.”

While it’s hard to tell much from a press release, it notes that Nokia’s digital health division makes and sells an ecosystem of hybrid smart watches, scales and digital health devices to consumers and enterprises. Its digital health history includes the acquisition of Withings, a French startup with a sexy line up of connected health-focused digital health devices.

This may be in part because it just hasn’t been aggressive enough or offered anything unique. In the wake of the Withings acquisition, Nokia doesn’t seem to have done much to build on Withings’ product line. Though much of the success in this market depends on execution, its current roster of products doesn’t sound like anything too exciting or differentiated.

It’s interesting to note that Buvac blames at least part of the failure of its digital health excursion on Nokia’s size. That doesn’t seem to be a problem for industry-leading companies like Apple, which seems to be carving out its digital health footprint one launch at a time and cultivating health leaders along the way. For example, Apple recently partnered with Stanford Medicine launch an app using its smartwatch to collect data on irregular heart rhythms. Arguably, this is the way to win markets and influence people — slow and steady.

In the end, though, Buvac is probably right about is digital health prospects. Nokia’s seeming failure may indeed be attributed to its sprawling portfolio, and probably an inflexible internal culture as well. The moral of the story may be that winning at the digital health game has far more to do with understanding the market than it does with having very deep pockets.

Hospitals Still Lagging On Mobile

Posted on January 18, 2018 I Written By

Anne Zieger is a healthcare journalist who has written about the industry for 30 years. Her work has appeared in all of the leading healthcare industry publications, and she's served as editor in chief of several healthcare B2B sites.

One would think that these days, when the desktop computer is an extension of mobile devices rather than the other way around, hospitals would have well-defined, mature plans in place for managing mobile technology. But according to one survey, that’s definitely not the case.

In a study sponsored by Spok, which provides clinical communication services, many healthcare providers are still in the early years of developing a mobile strategy.

The study, which drew on contacts with more than 300 healthcare professionals in the US, found that 21% had had a mobile strategy in place for less than one year, 40% for one to three years,14% for 3 to 5 years and 25% for more than five years. In other words, while one-quarter of organizations had settled in and developed a mobile approach, an almost equal amount were just getting their feet wet.

Not only that, many of those who do have a mobile strategy in place may be shooting from the hip. While 65% of those surveyed had a documented mobility strategy in place, 35% didn’t.

That being said, it seems that organizations that have engaged with mobile are working hard to tweak their strategy regularly. According to Spok, their reasons for updating the strategy include:

* Shifting mobile needs of end-users (44%)
* The availability of new mobile devices (35%)
* New capabilities from the EHR vendor (26%)
* Changes in goals of mobile strategy (23%)
* Challenges in implementing the strategy (21%)
* Changes in hospital leadership (16%)

(Seven percent said their mobile strategy had not changed since inception, and 23% weren’t sure what changes had been made.)

Nonetheless, other data suggest there has been little progress in integrating mobile strategy with broader hospital goals.

For example, while 53% wanted to improve physician-to-physician communications, only 19% had integrated mobile strategy with this goal. Fifty-three percent saw nurse-to-physician communications as a key goal, but only 18% had integrated this goal with their mobile plans. The gaps between other top strategies and integration with mobile plans were similar across the strategic spectrum.

Ultimately, it’s likely that it will take a team approach to bring these objectives together, but that’s not happening in the near future. According to respondents, the IT department will implement mobile in 82% of institutions surveyed, 60% clinical leadership, 37% doctors, 34% telecom department, 27% nurses and 22% outside help from consultants and vendors. (Another 16% didn’t plan to have a dedicated team in place.)

The whole picture suggests that while the hospital industry is gradually moving towards integrating mobile into its long-term thinking, it has a ways to go. Given the potential benefits of smart mobile use, let’s hope providers catch up quickly.

iOS vs Android Infographic

Posted on June 7, 2017 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 10 blogs containing over 8000 articles with John having written over 4000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 16 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

The iOS and Android debate is a good one that never seems to end. The good news is that the debate is really only iOS and Android now. However, the reality in my mind is that most healthcare app developers need to do both regardless.

That said, I think that this infographic illustrates some differences in the culture of the iOS ecosystem and the Android ecosystem. It’s not really surprising when you realize that there are only expensive iOS devices and so it’s no surprise that people with iOS devices have more money. Whereas there are high end Android devices and there are low end Android devices. I wonder if the numbers would be very similar between those who have high end Android devices and iOS. I bet those populations would be very similar.

What are your thoughts on the debate between iOS and Android? Does it really matter at this point?


Via: InvestmentZen.com

When Will Digital Health Concepts Reach the Doctor?

Posted on May 10, 2017 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 10 blogs containing over 8000 articles with John having written over 4000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 16 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

The always insightful Joseph Kvedar, MD, has a great post up where Joe gets a wake-up call from one of his advisors:

“Joe, when are we going to take all of these digital health concepts from the 30,000 foot level and get them into that 10 minute window that the doctor has with the patient?” It is not hyperbole to say that this put the last 20+ years of my career in a whole different perspective.

This is a good wake-up call for all of us in the space. Pushing digital health solutions down to the 10 min window a doctor has with a patient is the nirvana of what we’re doing and is incredibly challenging.

Dr. Kvedar suggested that we’ve already started to do this when he shared an example of how his PCP offered an eVisit option for follow-up to his in-person visit. I think that is a good example, but his insights into the 2nd phase offered a great look into where all of this is headed [emphasis added]:

Phase two will be the integration of tools like remote monitoring of diabetes and blood pressure. This is more tricky. The front-end work of monitoring remotely-derived values is done by either a non-physician clinician or, in some cases, a software algorithm. The doctor gets involved only when there is a complex medical judgment required. When deployed at scale, this approach extends the doctor across many more patients due to the one-to-many nature of the intervention.

Taking the recent interaction with my PCP as an example, remote monitoring would be considered a whole new channel of work, which doesn’t easily fit in to his workflow like an evisit does. It is hard to estimate its value, hard to predict how much impact it will have and hard to envision how to integrate it into clinical practice.

There are some real gems in this quote. My favorite is “The doctor gets involved only when there is a complex medical judgment required.” The future of healthcare IT is going to be built on this concept. When does a doctor need to get involved and when can another staff member or software algorithm address the situation? It will take us at least a decade or more to figure out this balance. Not to mention the workflow that will make sense.

Could the Future of Healthcare Not Include Telemedicine?

Posted on May 3, 2017 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 10 blogs containing over 8000 articles with John having written over 4000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 16 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

Recently the ATA (American Telemedicine Association) held their annual conference which looks at the telemedicine and telehealth industry. I’ve always wanted to attend the event, but they’ve never had it at a time or a location that worked out well for me. One of these days I’m going to add it to my schedule of healthcare IT conferences. Until then, at least I can follow along with the conference on Twitter.

Coming out of the opening plenary session was this really interesting quote about telemedicine tweeted by the ATA twitter account:

I’d probably add that Telemedicine is the natural evolution of healthcare and technology. In fact, it’s clear to me that there’s no practical reason we shouldn’t be doing telemedicine for a large portion of our interactions with the healthcare system. It won’t replace all of them, but it should replace a lot of them.

The title of this post asks the question “Could the Future of Healthcare Not Include Telemedicine?”

My answer to that question is that I see no healthcare future where telemedicine doesn’t play a major role. It’s taken us forever to figure out telemedicine reimbursement. We’ve made progress but still have a long way to go. However, I don’t see any reason why telemedicine would not be a part of the future of healthcare.

Or as Andrew Watson, MD said, “Telemedicine is the natural evolution of healthcare.” We’re going to naturally go there whether people like it or not. It’s hard to kick against evolution and that’s true for telemedicine too.

Digital Health, Mobile Health, mHealth, etc Is Just Health?

Posted on April 26, 2017 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 10 blogs containing over 8000 articles with John having written over 4000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 16 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

Last week, the big news in the world of healthcare IT was that HIMSS acquired Health 2.0. You can check out the great writeup of the acquisition by Andy Oram. This acquisition was interesting since Health 2.0 had largely tried to be the anti-HIMSS for so long. There were others doing so as well like the mHealth Summitt and the Connected Health Conference, but those have all been acquired by HIMSS as well.

It’s no surprise that running a conference focused on startup companies doing innovative things in healthcare is a hard business. Startup companies have no money and so they can’t spend on oversized booths like the large vendors at HIMSS do. Indu and Matthew did what they could with Health 2.0, but it’s a challenging business. It will be interesting to see how things go under the HIMSS umbrella.

I know that Matthew Holt who started Health 2.0 has been beating the drum for a long time that there’s no such thing as mobile health or mHealth or Digital Health. There’s just healthcare. So, in some ways it makes sense for something like Health 2.0 to be part of a healthcare IT organization like HIMSS.

For the most part, I agree with Matthew on there not being a difference. However, I think that what this misses is that within the healthcare IT world there are companies at different stages of development. I divide these companies into 3 categories: Large Enterprise Companies, Middle Tier Companies, and Startup Companies. We could slice and dice some more, but I think this is a good framework for thinking about the industry.

Whether you liked the description of digital health or mobile health or mHealth, those terms came to represent what most people would consider startup healthcare IT companies. That’s what Health 2.0 and a few other conferences came to represent. Despite many efforts on their part to expand in other ways, HIMSS has largely come to represent the large enterprise companies. They’ve done so in a really fantastic way, but these large enterprise companies kind of suck the wind out of events like the HIMSS Annual conference.

What’s interesting to me is that the middle tier healthcare IT companies haven’t really had a place to go. Sure, they might go to HIMSS, but they generally do smaller booths and they go to show they’re a player in the space versus going to attract customers and do business deals. Same goes for Health 2.0. They might attend Health 2.0 to see what’s happening in the market, but it’s not a great event for their businesses generally either.

Along those same lines, I think that most middle tier hospitals and healthcare organizations get left out as well. They’re too small to be able to be the pilot site for a startup company and they get lost at an event like HIMSS. These middle tier healthcare organizations are interesting because they have money to spend if they can find something that works. However, they don’t have the bandwidth to be someone’s innovation center for something that might work.

No doubt, digital health is just becoming part of the overall healthcare system. However, the division between size of companies and the maturity of their products is not going to change. Not to mention the needs of the various sized healthcare organizations. It will be interesting to see what happens to Health 2.0 under HIMSS and how the market continues to evolve to better serve its stakeholders.

MindCrowd Memory Test

Posted on April 19, 2017 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 10 blogs containing over 8000 articles with John having written over 4000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 16 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

This week I was the moderator at the DellEMC #TranformHIT Healthcare Think Tank event. It was a great event and if you missed it, you can search the #TranformHIT on Twitter or find the recording in the embedded video at the bottom of this post.

One of the highlights of the event for me was meeting Dr. Jeff Trent From TGen, a nonprofit institute focused on translating genomic research into life-changing results. The work they’re doing is really quite incredible and Dr. Trent offered some great insights at the Think Tank.

One of the research projects at TGen is called Mind Crowd. This research looks at memory and other brain related diseases. As part of the study, they’re trying to get 1 million people to participate in a fun, but simple mind test on their site. The test takes about 10 minutes, but try it out and see how you do.

What’s fascinating about the results they’ve already seen from the 74k+ people who have taken the test to date is that women of all ages actually have better memory than men. There are outliers, but across the data it’s very clear that in this test women remember things better than men.

To add to these findings, there’s also an interesting thing that happens when women approach the age of menopause. Women at that age seem to actually get an increase in their memory. It’s not clear why this is the case, but the data shows an uptick in memory about the time most women hit menopause.

Tgen is also taking the outliers and working with them to study why their memory is so much better or worse (ie. an older person with an incredible memory or a younger person with a poor memory). I’m interested to see what comes from these studies.

If you want to contribute to their research, take 10 minutes and go and participate in their Mind Test.
Read more..

23andMe Gets FDA Authorization for Consumer Genetic Health Risk Reports

Posted on April 11, 2017 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 10 blogs containing over 8000 articles with John having written over 4000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 16 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

The big news about 23andMe’s FDA approval came out last week when I was holed up at a conference.

That’s right. 23andMe can now directly offer consumers a genetic health risk report that’s FDA approved. This is a big step for 23andMe when you consider that they’d previously gotten their hand slapped by the FDA.

23andMe got what’s called a de novo authorization from the FDA. This is something we’re likely to see more of and something that I’m sure many people aren’t familiar with. Here’s a description of what a de novo authorization is from the 23andMe announcement:

What does it mean to be granted a de novo authorization?
The Food and Drug Administration Modernization Act of 1997 (FDAMA) added the de novo classification option, which provides an alternate pathway to classify novel devices of low to moderate risk. The de novo process is used by the FDA to grant marketing authorization for devices that are new and unlike any other on the market. In addition de novo marketing authorization means that 23andMe met the FDA’s premarket requirements to demonstrate the following: accuracy, validity and user comprehension.

I’m glad that the FDA has created this new form of authorization for companies like 23andMe. This story also stands in stark contrast to other FDA related stories like Theranos. I’m sure that 23andMe would hate the comparison. However, there are some similarities. They both got slapped by the FDA. However, their response to the FDA’s notices was completely different. That’s why 23andMe seems to still be thriving and now have FDA approval. Theranos is floundering with reports that their founder now owes the company $25 million.

Needless to say, if you’re a healthcare startup, make sure you know the FDA regulations that apply to your startup.

AliveCor Interview – Raises $30 Million

Posted on March 22, 2017 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 10 blogs containing over 8000 articles with John having written over 4000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 16 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

When I look across the mobile health ecosystem, one of the big winners is AliveCor. They’ve done an incredible job with their company and bringing their ECG readings to a much wider audience. The news recently came out that they’d raised their Series D round of investment of $30 million. As part of that announcement, my colleague Neil Versel from Meaningful Health IT News did an interview with the COO from AliveCor, Doug Biehn. You can check out the full interview below:

I hadn’t caught up with AliveCor for a while, so it was interesting to hear how much progress the company has made. Neil does a good job covering how AliveCor has been trying to figure out the balance between a consumer solution and a provider (FDA cleared) solution.

One of my favorite comments from the video above is when Neil asks about their new AlieCor platform and Doug Biehn says, “We’ve been launching new apps in the consumer space every 6 weeks for the past year, but this is our first big entree into the medical professional market.” I love this sort of iterative development in healthcare. While AliveCor does ECG, I think they’re just getting started. I’ll be interested to see what else comes out of this company as it continues to iterate and mature.